StonvexLoading…
StonvexStonvexStonvexCore line items from THO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $9.58B | $10.04B | $11.12B | $16.31B |
Operating Income | $296.19M | $348.84M | $499.35M | $1.46B |
Net Income | $258.56M | $265.31M | $374.27M | $1.14B |
EPS (Diluted) | $4.84 | $4.94 | $6.95 | $20.59 |
Total Assets | $7.07B | $7.02B | $7.26B | $7.41B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $586.60M | $501.32M | $441.23M | $311.55M |
Free Cash Flow OCF − CapEx | $456.31M | $405.93M | $772.73M | $749.55M |
Shares Outstanding | 53.40M | 53.69M | 53.86M | 55.26M |